Population-based studies on ovarian cancer providing survival estimates by age, histology, laterality, and stage have been sparse. We aimed to derive the most up-to-date and detailed survival ...
Health-related quality of life (HRQoL) results from the AURELIA trial evaluating bevacizumab (BEV) plus chemotherapy (CT) for platinum-resistant recurrent ovarian cancer (OC). Efficacy and safety of ...
Advanced-stage cancer carries a poor prognosis, and unfortunately the majority of cases are already at stage III-IV at the time of detection. Therefore, researchers have spent the past few decades ...
Early-stage ovarian cancer: Clinical outcome and analysis of prognostic factors—Results from a prospective registry of GEICO (Spanish Group for Ovarian Cancer Research). This is an ASCO Meeting ...
CHICAGO -- Clinical activity and survival outcomes improved with the addition of ipilimumab (Yervoy) to nivolumab (Opdivo) in patients with ovarian or other gynecologic clear cell carcinomas, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback